Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chloral Hydrate
Therapeutic Area : Sleep
Study Phase : Phase IV
Sponsor : Lindus Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmanovia Study Shows Chloral Hydrate Improves Severe Insomnia Within Two Weeks
Details : Chloral hydrate is converted rapidly to trichloroethanol, which is largely responsible for its hypnotic action. It is indicated for the treatment for severe insomnia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 01, 2024
Lead Product(s) : Chloral Hydrate
Therapeutic Area : Sleep
Highest Development Status : Phase IV
Sponsor : Lindus Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chloral Hydrate
Therapeutic Area : Sleep
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chloral Hydrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 26, 2023
Lead Product(s) : Chloral Hydrate
Therapeutic Area : Sleep
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable